Suturing vs Biological Adhesive in Simple Lacerations of Hand (sutvsglu)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00524888
Recruitment Status : Unknown
Verified August 2007 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : September 5, 2007
Last Update Posted : September 5, 2007
Information provided by:
Hadassah Medical Organization

September 4, 2007
September 5, 2007
September 5, 2007
September 2007
Not Provided
Wound appearance [ Time Frame: 3 Months ]
Same as current
No Changes Posted
pain of treatment and time length of treatment [ Time Frame: 3 months ]
Same as current
Not Provided
Not Provided
Suturing vs Biological Adhesive in Simple Lacerations of Hand
Suturing Vs Adhesion for Hand Lacerations in the ER A Randomized Prospective Study
To assess the difference in clinical outcome between lacerations in the hand treated by sutures versus treated by tissue adhesive.
Not Provided
Not Applicable
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
  • Procedure: suturing laceration
    suturing simple lacerations of the hand
  • Procedure: bioadhesive
    using bioadhesive on simple lacerations of the hand
  • Active Comparator: 1
    suturing lacerations of the hand
    Intervention: Procedure: suturing laceration
  • Active Comparator: 2
    using bioadhesive on lacerations of hand
    Intervention: Procedure: bioadhesive
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Unknown status
Same as current
Not Provided
Not Provided

Inclusion Criteria:

  • Any age
  • Hand laceration distal to the volar wrist crease.

Exclusion Criteria:

  • Fracture , tendon, artery involvement, more than 8 hours from laceration to trx,
  • Immunosuppression
  • Anticoagulation therapy
  • Diabetes
  • Unable to achieve homeostasis in more than 15 minutes
  • Unwilling to participate in the study
  • Unable to participate in the follow up or bite of any kind.
Sexes Eligible for Study: All
Child, Adult, Older Adult
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Not Provided
Hadassah Medical Organization
Not Provided
Principal Investigator: Michael Icekson, MD Hadassah Medical Organization
Hadassah Medical Organization
August 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP